The purpose of this study is to assess consumers' behaviors related to gabapentin self- selection and use, relative to warnings and directions for use, as described in the proposed over-the-counter (OTC) product label.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
1,254
Gabapentin 50 mg oral capsule 30 minutes before bedtime
Proportion of subjects who selected or purchased gabapentin for use (patients had symptoms consistent with indication and no contraindications)
Time frame: Throughout Day 90
Subject compliance with directions for use (number of capsules per dose and the number of doses per day)
Time frame: Throughout Day 90
Adverse events
Time frame: Duration of study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Pfizer Investigational Site
Anaheim, California, United States
Pfizer Investigational Site
Bonita, California, United States
Pfizer Investigational Site
Fallbrook, California, United States
Pfizer Investigational Site
Hacienda Heights, California, United States
Pfizer Investigational Site
La Mesa, California, United States
Pfizer Investigational Site
Oceanside, California, United States
Pfizer Investigational Site
Orange, California, United States
Pfizer Investigational Site
San Dimas, California, United States
Pfizer Investigational Site
Pembroke Pines, Florida, United States
Pfizer Investigational Site
Weston, Florida, United States
...and 25 more locations